Nervgen Pharma NGEN
NASDAQ NGEN
$1.35 +0.02 (+1.50%)
At close: Nov 11, 2026 · 4:00 PM EST

Nervgen Pharma (NGEN) Net Cash Flow (2025 - 2026)

Updated

Nervgen Pharma (NGEN) reported Net Cash Flow of $56.49 million for Q2 2026, compared with $3.43 million a year earlier.

Analysis

Nervgen Pharma (NGEN) Net Cash Flow (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Nervgen Pharma's Net Cash Flow came in at $62.84 million; for FY2025, it came in at $3.12 million, down 27.7% from FY2024.

  • By year, Net Cash Flow came in at $4.32 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -4.12 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -3.52 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.21 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.81 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.41 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -799.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.26 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 843.00 Mn
10 Nervgen Pharma 105.93 Mn 4.82 Mn - 56.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 56.49 Mn
Mar 31, 2026 2.03 Mn
Jun 30, 2025 3.43 Mn
Mar 31, 2025 888,133.63
API Access

Nervgen Pharma Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=NGEN&period=max&api_key=YOUR_API_KEY